Parallel trade in products already placed on the market is a lawful form of trade within the internal market on the basis of Article 34 TFEU subject to the limitations arising from the need for protection of health and safety and from the need for protection of intellectual property rights provided for under Article 36 TFEU. Application of the principle of parallel trade is, however, subject to different interpretations in the Member States. The conditions, in particular the requirements for relabelling and repackaging, should therefore be specified in this Regulation, taking into account the case-law of the Court of Justice [Judgment of 28 July 2011 in Orifarm and Paranova, joined cases C-400/09 and C-207/10, ECLI:EU:C:2011:519.] in other relevant sectors and existing good practice in the field of medical devices.
Recital 37, Regulation (EU) 2017/745
In forcesince 5 Apr 2017
Judgment of the Court (First Chamber) of 28 July 2011. Orifarm A/S and Others (C-400/09) and Paranova Danmark A/S and Paranova Pack A/S (C-2Decision
28 Jul 2011 · 62009CJ0400
- ecli=ECLI:UE:C:2011:519